In vitro profiling of endothelial volatile organic compounds under resting and pro-inflammatory conditions.


Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
03 10 2019
Historique:
received: 30 07 2019
accepted: 27 09 2019
entrez: 5 10 2019
pubmed: 5 10 2019
medline: 21 4 2020
Statut: epublish

Résumé

The evaluation of volatile organic compounds(VOCs) emitted by human body offers a unique tool to set up new non-invasive devices for early diagnosis and long-lasting monitoring of most human diseases. However, their cellular origin and metabolic fate have not been completely elucidated yet, thus limiting their clinical application. Endothelium acts as an interface between blood and surrounding tissues. As such, it adapts its physiology in response to different environmental modifications thus playing a role in the pathogenesis of many metabolic and inflammatory diseases. Since endothelium specifically reshapes its physiologic functions upon environmental changes the objective of this study was to evaluate if and how pro-inflammatory stimuli affect VOC metabolism in endothelial cell in culture. Gas chromatography with mass spectrometric detection was applied to profile VOCs in the headspace of cultured endothelial cells (EC) in the absence or presence of the pro-inflammatory stimulus lipopolysaccharide (LPS). We observed that, under resting conditions, EC affected the amount of 58 VOCs belonging to aldehyde, alkane and ketone families. Among these, LPS significantly altered the amount of 15 VOCs. ROC curves show a perfect performance (AUC = 1) for 10 metabolites including 1-butanol, 3-methyl-1-butanol and 2-ethyl-1-hexanol. The emission and uptake of the aforementioned VOCs disclose potential unexplored metabolic pathways for EC that deserve to be investigated. Overall, we identified new candidate VOC potentially exploitable, upon experimental confirm in in vivo model of disease, as potential biomarkers of sepsis and pro-inflammatory clinical settings.

Identifiants

pubmed: 31583479
doi: 10.1007/s11306-019-1602-6
pii: 10.1007/s11306-019-1602-6
doi:

Substances chimiques

Biomarkers 0
Lipopolysaccharides 0
Volatile Organic Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132

Références

J Breath Res. 2014 Mar;8(1):014001
pubmed: 24421258
Circ Res. 2018 Aug 3;123(4):477-494
pubmed: 30355249
Proteomics. 2006 Nov;6(22):5915-28
pubmed: 17106915
Pharmacol Res. 2016 Jun;108:46-56
pubmed: 27073018
Sci Rep. 2018 Apr 3;8(1):5539
pubmed: 29615722
Sci Rep. 2017 Mar 03;7:43969
pubmed: 28256598
Anesthesiology. 2015 Jan;122(1):117-26
pubmed: 25170570
J Intern Med. 2015 Mar;277(3):277-293
pubmed: 25418337
J Biol Chem. 2015 Feb 27;290(9):5449-61
pubmed: 25568324
Ann Hum Biol. 2013 Nov-Dec;40(6):463-71
pubmed: 23829164
Science. 2001 Nov 30;294(5548):1942-5
pubmed: 11729323
Cytokine. 2008 May;42(2):145-151
pubmed: 18304834
J Chromatogr. 1982 Apr 30;239:343-9
pubmed: 7096503
Front Physiol. 2018 Jun 07;9:524
pubmed: 29930512
Curr Med Chem. 2016;23(20):2112-31
pubmed: 27160536
Biomed Chromatogr. 2018 Apr;32(4):null
pubmed: 29131420
Mol Med. 2011 Mar-Apr;17(3-4):172-9
pubmed: 20957334
J Hematol Oncol. 2013 Aug 22;6:61
pubmed: 23965413
J Biol Chem. 2003 Nov 14;278(46):45117-27
pubmed: 12960176
Mol Pharmacol. 2002 Mar;61(3):614-9
pubmed: 11854442
Br J Surg. 2018 Oct;105(11):1493-1500
pubmed: 30019405
Innate Immun. 2015 Nov;21(8):827-46
pubmed: 26403174
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Thromb Haemost. 2002 Aug;88(2):335-44
pubmed: 12195709
Mol Cells. 2003 Jun 30;15(3):320-6
pubmed: 12872987
J Clin Invest. 1999 Apr;103(7):1007-13
pubmed: 10194473
J Cell Sci. 2013 May 1;126(Pt 9):1952-61
pubmed: 23447675
J Appl Physiol (1985). 2013 Nov;115(10):1487-95
pubmed: 23908314
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):182-95
pubmed: 20056637
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e108-e114
pubmed: 28835487
Anal Chim Acta. 2017 Dec 15;996:1-9
pubmed: 29137702
J Breath Res. 2012 Jun;6(2):027108
pubmed: 22621865
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
J Biol Chem. 2003 Feb 7;278(6):4353-7
pubmed: 12454009
J Med Biol Eng. 2016;36(5):605-624
pubmed: 27853412
Mol Biosyst. 2007 Feb;3(2):136-50
pubmed: 17245493
iScience. 2019 Jan 25;11:178-188
pubmed: 30612036
PLoS One. 2014 Apr 21;9(4):e95668
pubmed: 24752575
Biol Chem. 2018 Oct 25;399(11):1237-1248
pubmed: 29924722
Expert Rev Mol Diagn. 2019 Jan;19(1):47-61
pubmed: 30575423
Electrophoresis. 2015 Dec;36(23):2851-8
pubmed: 26257168
J Biol Chem. 1967 Feb 10;242(3):477-84
pubmed: 6022844
FEBS Lett. 1997 Mar 17;405(1):26-30
pubmed: 9094418
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jan 15;881-882:76-82
pubmed: 22209594
Lab Chip. 2019 Jan 15;19(2):198-205
pubmed: 30506070
J Breath Res. 2016 Mar 14;10(1):016016
pubmed: 26971584
Am J Respir Cell Mol Biol. 2017 Dec;57(6):662-673
pubmed: 28763253
J Lab Clin Med. 2000 Sep;136(3):243-9
pubmed: 10985503
J Nanosci Nanotechnol. 2018 Jan 1;18(1):522-528
pubmed: 29768877
J Clin Gastroenterol. 2015 Jan;49(1):1-8
pubmed: 25319742
Cell Biochem Biophys. 2015 Jan;71(1):323-9
pubmed: 25123840
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
Brain Behav Immun. 2018 Mar;69:312-320
pubmed: 29241669
J Breath Res. 2017 Apr 11;11(2):026003
pubmed: 28397711
J Pharmacol Sci. 2015 Oct;129(2):83-94
pubmed: 26499181
Adv Exp Med Biol. 2017;1003:71-91
pubmed: 28667554

Auteurs

V Longo (V)

National Research Council of Italy, Institute for Microelectronics and Microsystems, Lecce, Italy. valentina.longo@le.imm.cnr.it.

A Forleo (A)

National Research Council of Italy, Institute for Microelectronics and Microsystems, Lecce, Italy.

S Capone (S)

National Research Council of Italy, Institute for Microelectronics and Microsystems, Lecce, Italy.

E Scoditti (E)

National Research Council of Italy, Institute of Clinical Physiology, Lecce, Italy.

M A Carluccio (MA)

National Research Council of Italy, Institute of Clinical Physiology, Lecce, Italy.

P Siciliano (P)

National Research Council of Italy, Institute for Microelectronics and Microsystems, Lecce, Italy.

M Massaro (M)

National Research Council of Italy, Institute of Clinical Physiology, Lecce, Italy. marika.massaro@ifc.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH